Titre:
  • Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.
Auteur:Shi, W; Jiang, T; Nuciforo, P; Hatzis, Christos; Holmes, E; Harbeck, Nadia; Sotiriou, Christos; Peña, L; Loi, S.; Rosa, D D; Chia, S; Wardley, Andrew; Ueno, T; Rossari, J; Eidtmann, H; Armour, A; Piccart-Gebhart, Martine; Rimm, David D.L.; Baselga, J; Pusztai, L
Informations sur la publication:Annals of oncology, 29, 10, page (2152)
Statut de publication:Publié, 2018-10-01
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Médecine pathologie humaine
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdx805
info:pii/4986931
info:pmid/29701764
PMC6225898